百利天恒：股东OAPIII(HK)Limited拟减持不超1%公司股份

Core Viewpoint - OAPIII (HK) Limited plans to reduce its stake in Sichuan Baili Tianheng Pharmaceutical Co., Ltd. by up to 4.13 million shares, representing 1% of the company's total share capital, due to its own funding needs [1] Group 1 - OAPIII (HK) Limited currently holds 28,527,171 shares in the company, which accounts for 6.91% of the total share capital [1] - The shares to be sold were acquired prior to the company's initial public offering and will be released from restrictions on January 8, 2024, allowing them to be traded [1]